Private hospital group Mediclinic International expects results for the year to March 31 to be slightly ahead of forecasts, thanks to a turnaround in its Abu Dhabi business and better than expected revenue growth in its southern African division. Mediclinic operates hospitals and clinics in southern Africa, Switzerland and the Middle East, and holds a 29.9% stake in UK hospital group Spire Healthcare. It is listed on the London Stock Exchange, with a secondary listing on the JSE, and is due to release its annual results on May 24. Mediclinic said on Wednesday it expected the group would deliver a 2% increase in revenue in constant currency, but earnings before interest, tax, depreciation and amortisation (Ebitda) would be flat compared to the previous year. After the translation effect of foreign currency movements, revenue is expected to be up about 4% to £2.9bn, compared to £2.7bn the previous year. Adjusted earnings per share, which are affected by the equity accounted share of r...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.